UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

Nature genetics, 2016-09, Vol.48 (9), p.1031-1036

2016

Volltextzugriff (PDF)

Contribution of Common Genetic Variants to Antidepressant Response

Biological psychiatry (1969), 2013-04, Vol.73 (7), p.679-682

2013

Volltextzugriff (PDF)

Translating Human Genetics into Novel Treatment Targets for Schizophrenia

Neuron (Cambridge, Mass.), 2014-11, Vol.84 (3), p.537-541

2014

Volltextzugriff (PDF)

The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial

Neuropsychopharmacology (New York, N.Y.), 2023-06, Vol.48 (7), p.1052-1059

2023

Volltextzugriff (PDF)

Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4756-4768

2021

Volltextzugriff (PDF)

An Integrative Genomic Study Implicates the Postsynaptic Density in the Pathogenesis of Bipolar Disorder

Neuropsychopharmacology (New York, N.Y.), 2016-02, Vol.41 (3), p.886-895

2016

Volltextzugriff (PDF)

Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2013-04, Vol.368 (1615), p.20120435

2013

Volltextzugriff (PDF)

Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation

Journal of neurochemistry, 2009-11, Vol.111 (4), p.976-987

2009

Volltextzugriff (PDF)

Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes

Nature communications, 2014-10, Vol.5 (1), p.5236-5236, Article 5236

2014

Volltextzugriff (PDF)

Translating Neurogenomics into New Medicines

Biological psychiatry (1969), 2016-04, Vol.79 (8), p.650-656

2016

Volltextzugriff (PDF)

Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive–compulsive disorder

Neuroscience letters, 2014-09, Vol.580, p.100-103

2014

Volltextzugriff (PDF)

Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression

Neuropsychopharmacology (New York, N.Y.), 2019-05, Vol.44 (6), p.1163-1173

2019

Volltextzugriff (PDF)

Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys

Biological psychiatry (1969), 2005-01, Vol.57 (2), p.167-172

2005

Volltextzugriff (PDF)

The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder

Frontiers in pharmacology, 2019-11, Vol.10, p.1362-1362

2019

Volltextzugriff (PDF)

Pharmacogenetics of antidepressant response: A polygenic approach

Progress in neuro-psychopharmacology & biological psychiatry, 2017-04, Vol.75, p.128-134

2017

Volltextzugriff (PDF)

How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems

Neuropharmacology, 2008-11, Vol.55 (6), p.932-960

2008

Volltextzugriff (PDF)

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

Neuron (Cambridge, Mass.), 2015-12, Vol.88 (6), p.1078-1083

2015

Volltextzugriff (PDF)

miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells

The international journal of neuropsychopharmacology, 2013-04, Vol.16 (3), p.621-629

2013

Volltextzugriff (PDF)

Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1

Nature genetics, 2010-02, Vol.42 (2), p.128-131

2010

Volltextzugriff (PDF)

Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling

Molecular and cellular neuroscience, 2008-03, Vol.37 (3), p.440-453

2008

Volltextzugriff (PDF)

Gene Expression and Genetic Variation Data Implicate PCLO in Bipolar Disorder

Biological psychiatry (1969), 2011-02, Vol.69 (4), p.353-359

2011

Volltextzugriff (PDF)

A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder

Human molecular genetics, 2008-03, Vol.17 (5), p.717-723

2008

Volltextzugriff (PDF)

A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder

Neuropsychopharmacology (New York, N.Y.), 2007-12, Vol.32 (12), p.2543-2551

2007

Volltextzugriff (PDF)

Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder

Movement disorders, 2013-08, Vol.28 (9), p.1263-1270

2013

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(56)
Humans
(39)
Neurosciences & Neurology
(29)
Male
(28)
Neurosciences
(28)
Female
(26)
Animals
(25)
Psychiatry
(23)
Biological And Medical Sciences
(21)
Genotype
(18)
Medical Sciences
(17)
Pharmacology & Pharmacy
(14)
Rats
(14)
Genetics
(13)
Adult
(12)
Genome-Wide Association Study
(11)
Psychology. Psychoanalysis. Psychiatry
(11)
Serotonin Plasma Membrane Transport Proteins - Genetics
(11)
Obsessive-Compulsive Disorder - Genetics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

Contribution of Common Genetic Variants to Antidepressant Response

Translating Human Genetics into Novel Treatment Targets for Schizophrenia

Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis

The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial

Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A

An Integrative Genomic Study Implicates the Postsynaptic Density in the Pathogenesis of Bipolar Disorder

Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity

Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation

Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes

Translating Neurogenomics into New Medicines

Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive–compulsive disorder

Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression

Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys

The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder

Pharmacogenetics of antidepressant response: A polygenic approach

How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells

Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1

Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling

Gene Expression and Genetic Variation Data Implicate PCLO in Bipolar Disorder

A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder

A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder

Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder

Suchergebnisse filtern